Ticker Details
Candel Therapeutics, Inc. Common Stock
IPO Date:	July 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$623.53M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 5.25%
Avg Daily Range (30 D):	$0.29 | 3.66%
Avg Daily Range (90 D):	$0.22 | 3.51%

Institutional Daily Volume
Avg Daily Volume:	.84M
Avg Daily Volume (30 D):	1.98M
Avg Daily Volume (90 D):	1.53M

Trade Size
Avg Trade Size (Sh.):	155
Avg Trade Size (Sh.) (30 D):	116
Avg Trade Size (Sh.) (90 D):	112

Institutional Trades
Total Institutional Trades:	153
Avg Institutional Trade:	$1.24M
Avg Institutional Trade (30 D):	$.76M
Avg Institutional Trade (90 D):	$.76M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.38M
Avg Closing Trade (30 D):	$.79M
Avg Closing Trade (90 D):	$.79M
Avg Closing Volume:	200.5K

News

Feb 20, 2026 @ 1:56 PM Stock Market Today: Dow Jones, S&P 500 Futures Sl... Source: Rishabh Mishra

Feb 20, 2026 @ 2:40 AM Candel Therapeutics Announces Pricing of Public Of... Source: Na

Feb 19, 2026 @ 9:05 PM Candel Therapeutics Announces Proposed $100 Millio... Source: Globe Newswire

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.99	$-.14	$-.55
Diluted EPS	$-.99	$-.14	$-.55
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-54.42M	$-8.86M	$-29.5M
Operating Income / Loss	$-56.42M	$-16.28M	$-15.75M
Cost of Revenue
Net Cash Flow	$102.82M	$75.1M	$32.92M
PE Ratio